Cheap eye scanner could bring retinal checks to the masses
NCT ID NCT05530460
First seen Dec 08, 2025 · Last updated Jun 23, 2026 · Updated 26 times
Summary
This study tested a custom, low-cost eye imaging device to see if it can produce retinal images as good as those from expensive commercial machines. Eleven healthy adults had their retinas scanned with both devices. The goal was to check if the cheaper device could clearly show the retina's structure, which could help make eye screening more affordable worldwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTICAL COHERENCE TOMOGRAPHY OF RETINA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-cost optical coherence tomography device
What this could lead to
If successful, this could make retinal imaging more affordable and accessible, especially in low-resource settings.
What could go wrong
This is a very small, early-stage device comparison with only 11 participants. It does not test treatment or health outcomes, only image quality.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.